Sanofi, Provention Bio ink pact for launch of Diabetes drug Teplizumab Ruchika Sharma9 Oct 2022 4:00 PM ISTTeplizumab is an anti-CD3 monoclonal antibody that is being developed for the delay of clinical T1D in at-risk individuals, as indicated by the...
Sanofi expects positive boost from currency markets in Q3 Ruchika Sharma28 Sept 2022 4:34 PM ISTSanofi reports results denominated in the euro currency, and would therefore benefit from an increase in the value of the U.S dollar against the euro,...
EMA Committee recommends nod of Sanofi, AstraZeneca Beyfortus for prevention of RSV disease in infants Ruchika Sharma18 Sept 2022 3:00 PM ISTParis: Sanofi and AstraZeneca have recently announced that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has...
GSK, Sanofi see EU drugs regulator decision on COVID booster in weeks Ruchika Sharma6 Sept 2022 2:00 PM ISTThe vaccine could be used as a booster for people who had received any other COVID-19 vaccine, Triomphe said.
Sanofi gets USFDA nod for ASMD drug Xenpozyme Ruchika Sharma2 Sept 2022 3:57 PM ISTASMD, historically known as Niemann-Pick disease types A, A/B, and B, is an extremely rare, progressive genetic disease with significant morbidity and...
Sanofi stops breast cancer drug Amcenestrant Clinical Development Program Roshni Dhar19 Aug 2022 6:30 PM ISTPharma major, Sanofi, has announced the discontinuation of the global clinical development program of amcenestrant, an investigational oral selective...
Sanofi halts breast cancer drug Amcenestrant clinical development program Ruchika Sharma18 Aug 2022 1:15 PM ISTParis: Pharma major, Sanofi, has announced the discontinuation of the global clinical development program of amcenestrant, an investigational oral...
Sanofi, Innovent Biologics ink pact to accelerate development of oncology medicines in China Ruchika Sharma7 Aug 2022 12:30 PM ISTIn addition to the collaboration and license agreement, Sanofi will invest €300 million in Innovent through subscription of new common shares.
Sanofi Dupixent Phase 3 trial shows positive results in children with eosinophilic esophagitis as young as age 1 Ruchika Sharma16 July 2022 12:30 PM ISTEoE is a chronic inflammatory disease that damages the esophagus and prevents it from working properly.
Sanofi Global Health unveils new brand Impact for distribution of 30 medicines in low-income countries Ruchika Sharma4 July 2022 5:44 PM ISTConsidered essential by the World Health Organization, the medicines cover a wide range of therapeutic areas, including diabetes, cardiovascular...
USFDA places clinical hold on Phase 3 Tolebrutinib studies: Sanofi Ruchika Sharma2 July 2022 12:45 PM ISTThe FDA action was based on a limited number of cases of drug-induced liver injury that have been identified with tolebrutinib exposure in Phase 3...
GSK-Sanofi variant-specific COVID vaccine found effective against Omicron Ruchika Sharma24 Jun 2022 4:30 PM ISTParis: Sanofi and GSK today announced positive data from their vaccine trial which evaluated an adjuvanted bivalent D614 and Beta (B.1.351) vaccine...
